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In this case presentation, the authors discuss the prevalence, diagnosis 
and surgical treatment of the exceedingly rare primary laryngeal 
melanoma. The importance of immunohistochemical investigations is 
emphasised since the condition tends to mimic laryngeal carcinomas. 
Laryngeal melanomas have a very poor prognosis; their five-year 
survival is less than 10% in international literature. However, the patient 
presented in this article is still asymptomatic and has no metastases 
7 years after the removal of the lesion with transoral laser microsurgery.  
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Introduction 
International scientific literature reports a few 
cases of rare malignant tumours of the larynx, 
such as neuroendocrine carcinoma, solitary 
extramedullary plasmocytoma or 
lymphangiosarcoma of the vocal cords (1, 2, 
3,). However, there is hardly any mention of 
the primary melanoma of the larynx, since it is 
such a rare condition.  
Mucosal melanoma accounts for approx. 9% 
to 10% (4) of head and neck melanoma cases, 
which is only 1.3% of the overall prevalence 
of melanomas (5, 6). Head and neck mucosal 
melanomas primarily affect the oral and nasal 
cavity, as well as the paranasal sinuses (4). 
Primary laryngeal melanoma is such a rare 
condition, which the lesion may be considered 
an epidermoid carcinoma before the 
histological diagnosis is established.  It is most 
commonly detected in the glottic and 
supraglottic regions on direct and indirect 
laryngoscopy (7, 8). Similarly to the 
planocellular carcinoma of the larynx, it 
invariably affects heavy smokers. However, it 
has also presented as the malignant 
transformation of laryngeal papillomas, and 
chronic irritation in conjunction with other 
carcinogenic factors may also play a role in its 
development (9).  
Depending on the location, patients usually 
present with hoarseness, laryngeal-pharyngeal 
irritation, pain on swallowing that radiates to 
the ear, and dyspnoea in the later stages. 
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The scarce literature data suggest a very poor 
prognosis as a result of early and aggressive 
metastases, the five-year survival is less than 
10% (7). 
The aim of this paper is to draw attention to 
this rare condition since the clinical entity has 
to be taken into consideration in certain cases. 
In addition, we would like to present a success 
story, as 5 years after the removal of the lesion 
with transoral laser microsurgery the patient is 
still asymptomatic and has no metastases.   
 
Case presentation 
A 69-year-old male patient had been 
experiencing hoarseness for one year. In the 
previous six months, accompanying dyspnoea 
had also developed. He had no dysphagia or 
pain radiating to his ear.  He also had a 
persistent cough as he had been smoking 20 
cigarettes per day for 51 years. He consumed 
beer and spirits regularly. He had no 
concomitant diseases except for hypertension. 
One month prior to his admission, he 
underwent laryngomicroscopy and biopsy 
from the larynx in another institution, and 
histopathology revealed high-grade 
sarcomatoid carcinoma of the larynx. He was 
then referred to our clinic for further 
management. 
On indirect laryngoscopy, a greyish, uneven-
surfaced tumour was visible on the right vocal 
cord, extending through the anterior 
commissure until the anterior third of the left 
vocal cord, moderately narrowing the 
laryngeal lumen. The mobility of both vocal 
cords was intact and no other disease was 
present in the larynx or hypopharynx. Lymph 
nodes were not palpable on the neck. 
Direct pharyngo-laryngoscopy was carried out; 
we found the picture of a T1/b glottic tumour 
(Figure 1). 
Laryngomicroscopy was done, during which 
we resected the right vocal fold with CO2 laser 
(in order to have a better visualisation of the 
vocal cord) and did an extended laser 
cordectomy (V/a,c. European Laryngological 
Society 2000) (Figure 2). 
 
Figure 1. Preoperative endoscopic image of the 
right-sided laryngeal tumour. 
 
 
Figure 2. Postoperative endoscopic picture: two 
weeks following right-sided laser cordectomy 
 
Pathological findings 
Macroscopically the specimen consisted of 
three tissue fragments (25×14×14, 12×10×4 
and 18×12×32 mm), partly covered by surface 
epithelium. Approximately half of the 
specimen consisted of malignant tissue. Cut 
surfaces were grey and white.Microscopically 
the tumour had a predominantly solid growth 
pattern. The cellular infiltrate included 
epitheloid cells and spindle-shaped cells with 
large round to oval vesicular nuclei, prominent 
eosinophilic nucleoli and variable amount of 
eosinophilic to clear cytoplasm (Figure 3). 
In some areas, cytoplasmic melanin pigment 
was seen. There was an increased mitotic 
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activity (6-7 mitotic cells/HPF). The surface 
epithelium showed areas with hyperplasia, in 
other parts it was atrophic or completely 
ulcerated. The depth of the tumour was 5-6 
mm and in some areas it reached the surgical 
margin (Figure 3).  
 
 
Figure 3. Exulcerated tumour of the larynx, with 
predominantly epitheloid tumour cells 
(hematoxilin-eosin, original magnification ×50, 
insert ×400). 
 
Microscopically the maximum tumour 
extension was 12 mm. Immunhistochemically 
the tumour cells showed strong Vimentin, S-
100 protein HMB-45 and Melan A/MART 1 
expression (Figure 4, Figure 5). KL-1 
(pancytokeratin), P63 and Desmin were all 
negative. The pathological diagnosis was 
malignant melanoma of the larynx (10). 
 
 
Figure 4. Strong Vimentin (left) and S-100 protein 
(right) immunoreactivity of the tumour cells 
(×400). 
 
Figure 5. Strong immunoreactivity of the tumour 
cells with the more specific markers of malignant 
melanoma HMB-45 (left) and Melan-A/MART-1 
(right) (×400). 
 
Discussion  
In our case presentation, we reported a rare 
case of stage T1/b malignant laryngeal 
melanoma, which seemed to be glottic 
laryngeal carcinoma clinically; however, 
immunohistochemical staining proved 
otherwise. The patient is a 69-year-old long-
term male smoker. 
Dermatological and ophthalmological 
investigations and PET/CT failed to detect 
other affected locations. Therefore, the final 
diagnosis was primary malignant melanoma of 
the larynx, which is a very rare laryngeal 
malignancy (11). 
Our aim is to draw attention to this rare type of 
laryngeal malignancy, since 90% of glottic 
laryngeal tumours normally turn out to be of 
squamous cell origin (12, 13). 
According to the recommendations of the 
European Laryngological Society, the 
treatment of choice for primary laryngeal 
melanomas not accompanied by disability 
should focus on ‘quality of life’, since 
extended laser cordectomy seems to be an 
effective way of management in 85-95% of 
T1-T2 glottic carcinomas (V-VI) (European 
Laryngological Society 2000) (14, 15). 
However, the only safe surgical management 
of local recurrence is laryngectomy. In the 
literature, most authors report laser resection 
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(extirpation) or total laryngectomy, depending 
on the extent of the melanoma within the 
larynx (7). Although most melanomas tend to 
be radioresistant, some authors still apply 
adjunctive irradiation postoperatively, 
sometimes combined with chemotherapy (8, 
17). 
Secondary laryngeal melanomas are melanoma 
metastases presenting in the larynx, which can 
also be managed with extended laser 
cordectomy (V-VI). However, local recurrence 
can only be managed with total laryngectomy. 
The above-mentioned methods of surgical 
management are sometimes complemented 
with systemic chemotherapy or 
chemohormonal treatment (17). 
Even though melanoma is thought to be 
radioresistant, some authors complement the 
surgical treatment of secondary laryngeal 
melanoma (laser excision, partial resection of 
the larynx, total laryngectomy) with 
irradiation, while others apply adjuvant 
chemotherapy (7, 10, 18).  
The macroscopic diagnosis of laryngeal 
melanomas is fairly unreliable. Therefore, 
histological and immunohistochemical 
findings are inevitable for an accurate 
diagnosis.  
The color of the intralaryngeal lesion may 
raise physicians’ suspicion: characteristic 
colors are grey, brown or black (19). The grey 
neoplastic lesion we presented could not be 
reliably classified as a primary or secondary 
laryngeal carcinoma; it may as well have been 
an epidermoid carcinoma. Thus, pathological 
immunohistological staining is essential for an 
accurate diagnosis. 
 
Conclusions 
Primary laryngeal carcinoma is a very rare 
type of malignancy associated with a very 
poor prognosis. Its macroscopic appearance is 
hard to distinguish from an epidermoid 
carcinoma. Therefore, pathological 
immunohistological staining is essential for an 
accurate diagnosis. 
Cases detected early can be managed with 
extended laser cordectomy, which is a minimal 
invasive intervention sparing laryngeal 
function. However, this clinical entity tends to 
be very aggressive and metastasize. Therefore, 
close monitoring and follow-up is necessary in 
the postoperative period in order to exclude 
regional and distant metastases. This case is 
considered a success story, since 7 years after 
the surgical intervention the patient has not 
developed recurrence or any metastases.  
 
Acknowledgments 
Not declared. 
 
Conflicts of Interest 
The authors declare no conflicts of interest. 
 
Financial Support 
Not declared. 
 
References 
1. Patel KJ, Chandana SR, Wiese DA, Olsen B, 
Conley BA. Unusual Presentation of Large-Cell 
Poorly Differentiated Neuroendocrine Carcinoma of 
the Epiglottis. Journal of Clinical Oncology 28: 461-
3,2010. 
2. Vanan I, Redner A, Atlas M, Marin L, Kadkade P, 
Bandovic J, Jaffe ES.. Solitary Extramedullary 
Plasmocytoma of the Vocal Cord in an Adolescent. 
Journal of Clinical Oncology 27: 244-247,2009. 
3. Yu L, Yang SJ: Lymphangiosarcoma of the Vocal 
Cord: A Rare Entity  Defined by a D2-40 
Immunhistochemical and Ultrastructural Study. 
Journal of  Clinical Oncology 29: 57-61, 2011. 
4. Mendenhall WM, Amdur RJ, Hinerman RW, 
Werning JW, Villaret DB, Mendenhall NP. Head and 
neck mucosal melanoma. Am J Clin Oncol, 28:626–
30,2005. 
5. Sirikanjanapong S, Lanson B, Amin M, Martiniuk 
F, Kamino H, Wang BY. Collision tumour of primary 
laryngeal mucosal melanoma and invasive squamous 
cell carcinoma with IL-17A and CD70 gene over-
expression. Head Neck Pathol, 4:295–9,2010. 
6. Chang AE, Karnell LH, Menck HR. The National 
Cancer Data Base report on cutaneous and 
noncutaneous melanoma: a summary of 84,836 cases 
from the past decade. The American College of 
Surgeons Commission on Cancer and the American 
Cancer Society. Cancer, 83:1664–78,1998. 
Case Report 
Journal of Otorhinolaryngology and Facial Plastic Surgery 2020;6(1):1-5. 
https://doi.org/10.22037/orlfps.v6i1.32242 
------------------------------------------------------------------------------------------------------------------  
This work is distributed under the terms of the Creative Commons Attribution Non Commercial 4.0 License 
(CC BY-NC 4.0). 
5 
7. Terada T, Saeki N, Toh K, Uwa N, Sagawa K, 
Mouri T, Sakagami M. Primary malignant melanoma 
of the larynx: a case report and literature review. 
Auris Nasus Larynx, 34:105–10,2007. 
8. Amin HH, Petruzzelli GJ, Husain AN, Nickoloff 
BJ. Primary malignant melanoma of the larynx. Arch 
Pathol Lab Med, 125:271–273,2001. 
9. Wagner M, Morris CG, Werning JW, Mendenhall 
WM. Mucosal melanoma of the head and neck. Am J 
Clin Oncol,31:43–8,2008. 
10. Wenig BM. Laryngeal mucosal malignant 
melanoma: clinicopathologic, immunhistochemical, 
and ultrastructal study of four patients and review of 
the litaraure. Cancer. 75:1568-77,1995. 
11. Tomonori Tereda: Primary malignant melanoma 
of the larynx: A case report and literature review 
Aurus Nasus Larynx 34:105-10,2007. 
12. Hesham M.: Primary Malignant Melanoma of the 
larynx. Arch Pathol Lab Med.125:271-3,2001. 
13. Lefevre JL,Pignat JC, Chevalier D: Cancer du 
laryn -Éditions techniques- Encycl Med Chir (Paris-
France), Oto-rhino-laryngologie, 20-710-A-10,1993. 
14. Reuter VE, Woodruff JM: Melanoma of the 
larynx. Laryngoscope 94:389-93,1986. 
15. Schultz P: Vocal fold cancer. European Annals of 
Otorhinolaryngology, Head and Neck diseases 
128:301-8,2011. 
16. Blatchford SJ, Koopman CF, Coulthard SW: 
Mucosal melanoma of the head and neck. 
Laryngoscope 96:929-34,1986. 
17. Wenig BM: Laryngeal mucosal malignant 
melanoma. A clinicopathologic, immunhistochemical, 
and ultrastructural study of four patients and review of 
the literature. Cancer 75:1568-77,1995. 
18. Lanson BG, Sanfilippo N, Wang B, Grew D, 
DeLacure MD. Malignant melanoma metastatic to the 
larynx: treatment and functional outcome. Current 
Oncology 17: 127-32,2010. 
19. Ahmad S, Abdelghany M, GoldblattC, Stark O, 
Masciotra N. A case of primary subglottic malignant 
melanoma with succesful surgical treatment. Case 
Rep Oncol Med, 2014:968926,2014. 
 
